SCHB ETF holdings (NYSE) - Page 106 | MetaTrader

Tam grafiği aç

Genel Bakış Tüm yatırımlar Isı Haritası

En büyük yatırımlar Market Value Shares Weight %

SABR Sabre Corp 282.7646 K 239.6310 K 0.0007%

MLR Miller Industries Inc/TN 282.2735 K 6 716.0000 0.0007%

KRUS Kura Sushi USA Inc 281.5791 K 3 998.0000 0.0007%

INN Summit Hotel Properties Inc 280.8422 K 62.2710 K 0.0007%

ARKO Arko Corp 279.7436 K 43.5060 K 0.0007%

BOW Bowhead Specialty Holdings Inc 278.1994 K 10.9830 K 0.0007%

HGTY Hagerty Inc 277.4749 K 23.6350 K 0.0007%

DSGN Design Therapeutics Inc 276.0649 K 26.4430 K 0.0007%

BBOT BridgeBio Oncology Therapeutics Inc 275.8250 K 27.5000 K 0.0007%

CTKB Cytek Biosciences Inc 275.2960 K 61.4500 K 0.0007%

IIIV I3 Verticals Inc 273.9983 K 12.2430 K 0.0007%

IMXI International Money Express Inc 273.9724 K 17.3620 K 0.0007%

CHCT Community Healthcare Trust Inc 273.4400 K 16.0000 K 0.0007%

BWMN Bowman Consulting Group Ltd 272.2442 K 8 117.0000 0.0007%

BLMN Bloomin' Brands Inc 271.7953 K 44.4110 K 0.0007%

TDUP ThredUp Inc 271.7282 K 55.6820 K 0.0007%

ASIX AdvanSix Inc 270.7664 K 15.1860 K 0.0007%

FLOC Flowco Holdings Inc 270.7200 K 12.0000 K 0.0007%

MVST Microvast Holdings Inc 270.6726 K 120.8360 K 0.0007%

SION Sionna Therapeutics Inc 269.8844 K 7 386.0000 0.0007%

Haberler

SCHB: SCHB: A Hold Amid Premium Valuations And Higher Risk-Free Rates (NYSEARCA:SCHB)

Large Caps - Big Opportunity

3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately (NYSEARCA:SCHB)

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify

Patience Pays: ETFs You Can Buy and Hold for the Long Run

3 Best ETFs to Invest In, According to AI Analyst, 2/5/2026 - TipRanks.com

SCHB: The Conflict Between Short- And Long-Term Risks (NYSEARCA:SCHB)

ETFs to Keep Your Portfolio on Track in the Long Term

SCHB: Core Equity Holding For Diversified Investors (NYSEARCA:SCHB)

Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope

Equity Outlook: From Caution To Complacency?